- Generated second quarter 2021 total revenue of $12.5 million, an increase of 258% compared to the prior year period, including;
- Surgical Glaucoma sales of $12.0 million, an increase of 263% compared to the prior year period
- Dry Eye sales of $0.5 million, an increase of 169% compared to the prior year period
- Expanded gross margin to 82% in the second quarter 2021 versus 40% in the prior year period
- Completed an initial public offering in July raising approximately $253 million of net proceeds after deducting underwriting discounts and commissions and estimated offering expenses
Morgan Stanley Maintains Equal-Weight on Simply Good Foods, Lowers Price Target to $39
Morgan Stanley analyst Pam Kaufman maintains Simply Good Foods (NASDAQ:SMPL) with a Equal-Weight and lowers the price target from $41 to $39.
